Abstract-Renin initiates angiotensin II formation and has no other known functions. We observed that transgenic rats (TGR) overexpressing the human renin gene (hREN) developed moderate obesity with increased body fat mass and glucose intolerance compared with nontransgenic Sprague-Dawley (SD) rats. The metabolic changes were not reversed by an angiotensin-converting enzyme inhibitor, a direct renin inhibitor, or by (pro)renin receptor blocker treatment. The obese phenotype in TGR(hREN) originated from higher food intake, which was partly compensated by increases in resting energy expenditure, total thermogenesis (postprandial and exercise activity), and lipid oxidation during the first 8 weeks of life. Once established, the difference in body weight between TGR(hREN) and SD rats remained constant over time. When restricted to the caloric intake of SD, TGR(hREN) developed an even lower body weight than nontransgenic controls. We did not observe significant changes in the cocaine and amphetamine-regulated transcript, pro-opiomelanocortin, both anorexigenic, or neuropeptide Y, orexigenic, mRNA levels in TGR(hREN) versus SD controls. However, the mRNA level of the agouti-related peptide, orexigenic, was significantly reduced in TGR(hREN) versus SD controls at the end of the study, which indicates a compensatory mechanism. We suggest that the human renin transgene initiates a process leading to increased and early appetite, obesity, and metabolic changes not related to angiotensin II. The mechanisms are independent of any currently known renin-related effects. Key Words: renin-angiotensin system Ⅲ obesity Ⅲ metabolic syndrome Ⅲ ACE inhibitors Ⅲ renin inhibitors Ⅲ (pro)renin receptor Ⅲ handle region peptide O besity is largely responsible for the metabolic syndrome that clusters dyslipidemia, insulin resistance, glucose intolerance/type 2 diabetes mellitus, and hypertension. 1-3 The renin-angiotensin system is fundamental to blood pressure regulation, volume control, and salt balance through the action of angiotensin (Ang) II. 4 Renin is an aspartyl protease that cleaves angiotensinogen, leading to Ang I and subsequently to Ang II formation via the Ang-converting enzyme (ACE). Several renin/prorenin animal models feature metabolic alterations. [5][6][7] Mice solely harboring the human renin gene developed obesity. 7 Rats overexpressing the mouse Ren-2 gene exhibit insulin resistance. 5,6,8 However, this model is not obese, probably because of the severe hypertension and its sequelae. 8 Takahashi et al 9 reported recently that renin-deficient mice (Ren1c Ϫ/Ϫ ) were lean, insulin sensitive, and resistant to diet-induced obesity. Nguyen et al 10 cloned a novel (pro)renin receptor [(P)RR]. The receptor is expressed in a various tissues, including adipocytes. 11 The (P)RR promotes direct renin actions independent of Ang II. 12,13 The binding is specific for renin and prorenin, and the receptor enhances renin catalytic activity and unmasks receptor-bound prorenin catalytic activity. 10 The binding of (pro)renin to the recep...